Cargando…
Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients
BACKGROUND: Vitiligo is one of the most common hypomelanoses, in which the destruction of functioning melanocytes causes depigmentation of the skin, hair and mucous membranes. The genes encrypting brain-derived neurotrophic factor (BDNF) and corticotropin releasing hormone (CRH) might be the conceiv...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337645/ https://www.ncbi.nlm.nih.gov/pubmed/35905107 http://dx.doi.org/10.1371/journal.pone.0271719 |
_version_ | 1784759797412790272 |
---|---|
author | Kussainova, Assiya Kassym, Laura Bekenova, Nazira Akhmetova, Almira Glushkova, Natalya Kussainov, Almas Urazalina, Zhanar Yurkovskaya, Oxana Smail, Yerbol Pak, Laura Semenova, Yuliya |
author_facet | Kussainova, Assiya Kassym, Laura Bekenova, Nazira Akhmetova, Almira Glushkova, Natalya Kussainov, Almas Urazalina, Zhanar Yurkovskaya, Oxana Smail, Yerbol Pak, Laura Semenova, Yuliya |
author_sort | Kussainova, Assiya |
collection | PubMed |
description | BACKGROUND: Vitiligo is one of the most common hypomelanoses, in which the destruction of functioning melanocytes causes depigmentation of the skin, hair and mucous membranes. The genes encrypting brain-derived neurotrophic factor (BDNF) and corticotropin releasing hormone (CRH) might be the conceivable contributors to the development of vitiligo. This study was aimed at investigation of the serum levels of BDNF and CRH as well as their selected single nucleotide polymorphisms (SNPs) in vitiligo patients in comparison with the healthy controls. METHODS: The cross-sectional study was carried out between October 2020 and June 2021 in 93 vitiligo patients (age range from 23 to 48 years) and 132 healthy controls (age range from 24 to 52 years). The psychological status of study participants was evaluated using the Generalized Anxiety Disorder-7 (GAD-7) scale. Serum levels of BDNF and CRH were measured with the help of a commercially available sandwich enzyme-linked immunosorbent assay (ELISA) kit. Genotyping for the rs11030094 polymorphism of the BDNF gene and for the rs242924 polymorphism of the corticotropin releasing hormone receptor 1 (CRH-R1) gene was performed by a real-time polymerase chain reaction (PCR). RESULTS: There was a significant relationship between the CRH-R1 rs242924 and BDNF rs11030094 polymorphisms and vitiligo. Moreover, serum levels of neurotransmitters differed significantly between vitiligo and control groups and were associated with the CRH-R1 rs242924 and BDNF rs11030094 SNPs. CONCLUSIONS: Our findings demonstrated the association between CRH-R1 rs242924 and BDNF rs11030094 polymorphisms and vitiligo. Further studies need to be carried out in vitiligo patients to confirm the results observed. |
format | Online Article Text |
id | pubmed-9337645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-93376452022-07-30 Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients Kussainova, Assiya Kassym, Laura Bekenova, Nazira Akhmetova, Almira Glushkova, Natalya Kussainov, Almas Urazalina, Zhanar Yurkovskaya, Oxana Smail, Yerbol Pak, Laura Semenova, Yuliya PLoS One Research Article BACKGROUND: Vitiligo is one of the most common hypomelanoses, in which the destruction of functioning melanocytes causes depigmentation of the skin, hair and mucous membranes. The genes encrypting brain-derived neurotrophic factor (BDNF) and corticotropin releasing hormone (CRH) might be the conceivable contributors to the development of vitiligo. This study was aimed at investigation of the serum levels of BDNF and CRH as well as their selected single nucleotide polymorphisms (SNPs) in vitiligo patients in comparison with the healthy controls. METHODS: The cross-sectional study was carried out between October 2020 and June 2021 in 93 vitiligo patients (age range from 23 to 48 years) and 132 healthy controls (age range from 24 to 52 years). The psychological status of study participants was evaluated using the Generalized Anxiety Disorder-7 (GAD-7) scale. Serum levels of BDNF and CRH were measured with the help of a commercially available sandwich enzyme-linked immunosorbent assay (ELISA) kit. Genotyping for the rs11030094 polymorphism of the BDNF gene and for the rs242924 polymorphism of the corticotropin releasing hormone receptor 1 (CRH-R1) gene was performed by a real-time polymerase chain reaction (PCR). RESULTS: There was a significant relationship between the CRH-R1 rs242924 and BDNF rs11030094 polymorphisms and vitiligo. Moreover, serum levels of neurotransmitters differed significantly between vitiligo and control groups and were associated with the CRH-R1 rs242924 and BDNF rs11030094 SNPs. CONCLUSIONS: Our findings demonstrated the association between CRH-R1 rs242924 and BDNF rs11030094 polymorphisms and vitiligo. Further studies need to be carried out in vitiligo patients to confirm the results observed. Public Library of Science 2022-07-29 /pmc/articles/PMC9337645/ /pubmed/35905107 http://dx.doi.org/10.1371/journal.pone.0271719 Text en © 2022 Kussainova et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kussainova, Assiya Kassym, Laura Bekenova, Nazira Akhmetova, Almira Glushkova, Natalya Kussainov, Almas Urazalina, Zhanar Yurkovskaya, Oxana Smail, Yerbol Pak, Laura Semenova, Yuliya Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients |
title | Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients |
title_full | Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients |
title_fullStr | Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients |
title_full_unstemmed | Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients |
title_short | Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients |
title_sort | gene polymorphisms and serum levels of bdnf and crh in vitiligo patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337645/ https://www.ncbi.nlm.nih.gov/pubmed/35905107 http://dx.doi.org/10.1371/journal.pone.0271719 |
work_keys_str_mv | AT kussainovaassiya genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT kassymlaura genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT bekenovanazira genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT akhmetovaalmira genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT glushkovanatalya genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT kussainovalmas genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT urazalinazhanar genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT yurkovskayaoxana genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT smailyerbol genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT paklaura genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients AT semenovayuliya genepolymorphismsandserumlevelsofbdnfandcrhinvitiligopatients |